Chemotherapy of recurrent ovarian carcinoma with cis-dichloro-diammine platinum II and adriamycin

Robert C. Wallach; Carmel Cohen; Howard Bruckner; Bernard Kabakow; Gunter Deppe; Lynn Ratner

doi:10.1097/00006250-198003000-00020

Chemotherapy of recurrent ovarian carcinoma with cis-dichloro-diammine platinum II and adriamycin

Robert C. Wallach, Carmel Cohen, Howard Bruckner, Bernard Kabakow, Gunter Deppe, Lynn Ratner

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Forty-six patients with recurrent disseminated ovarian carcinoma were treated with a combination of cis-dichloro-diammine platinum II (DDP) 50 mg/m²and adriainycin 50 mg/m²given intravenously every 3 weeks. All patients had failed prior chemotherapy. The combination of adriamycin and DDF produced objective responses in 14 of 46 patients. Severe side effects were frequent, but no patient died as a result of treatment. Disease in 4 of 7 complete responders is currently in remission up to 4 years.

Original language	English
Pages (from-to)	371-372
Number of pages	2
Journal	Obstetrics and Gynecology
Volume	55
Issue number	3
DOIs	https://doi.org/10.1097/00006250-198003000-00020
State	Published - Mar 1980
Externally published	Yes

Access to Document

10.1097/00006250-198003000-00020

Cite this

@article{19d6df4c696b4d8b9c15e9b120ee8742,

title = "Chemotherapy of recurrent ovarian carcinoma with cis-dichloro-diammine platinum II and adriamycin",

abstract = "Forty-six patients with recurrent disseminated ovarian carcinoma were treated with a combination of cis-dichloro-diammine platinum II (DDP) 50 mg/m2and adriainycin 50 mg/m2given intravenously every 3 weeks. All patients had failed prior chemotherapy. The combination of adriamycin and DDF produced objective responses in 14 of 46 patients. Severe side effects were frequent, but no patient died as a result of treatment. Disease in 4 of 7 complete responders is currently in remission up to 4 years.",

author = "Wallach, {Robert C.} and Carmel Cohen and Howard Bruckner and Bernard Kabakow and Gunter Deppe and Lynn Ratner",

year = "1980",

month = mar,

doi = "10.1097/00006250-198003000-00020",

language = "English",

volume = "55",

pages = "371--372",

journal = "Obstetrics and Gynecology",

issn = "0029-7844",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Chemotherapy of recurrent ovarian carcinoma with cis-dichloro-diammine platinum II and adriamycin

AU - Wallach, Robert C.

AU - Cohen, Carmel

AU - Bruckner, Howard

AU - Kabakow, Bernard

AU - Deppe, Gunter

AU - Ratner, Lynn

PY - 1980/3

Y1 - 1980/3

N2 - Forty-six patients with recurrent disseminated ovarian carcinoma were treated with a combination of cis-dichloro-diammine platinum II (DDP) 50 mg/m2and adriainycin 50 mg/m2given intravenously every 3 weeks. All patients had failed prior chemotherapy. The combination of adriamycin and DDF produced objective responses in 14 of 46 patients. Severe side effects were frequent, but no patient died as a result of treatment. Disease in 4 of 7 complete responders is currently in remission up to 4 years.

AB - Forty-six patients with recurrent disseminated ovarian carcinoma were treated with a combination of cis-dichloro-diammine platinum II (DDP) 50 mg/m2and adriainycin 50 mg/m2given intravenously every 3 weeks. All patients had failed prior chemotherapy. The combination of adriamycin and DDF produced objective responses in 14 of 46 patients. Severe side effects were frequent, but no patient died as a result of treatment. Disease in 4 of 7 complete responders is currently in remission up to 4 years.

UR - http://www.scopus.com/inward/record.url?scp=0018831047&partnerID=8YFLogxK

U2 - 10.1097/00006250-198003000-00020

DO - 10.1097/00006250-198003000-00020

M3 - Article

C2 - 7189048

AN - SCOPUS:0018831047

SN - 0029-7844

VL - 55

SP - 371

EP - 372

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

IS - 3

ER -

Chemotherapy of recurrent ovarian carcinoma with cis-dichloro-diammine platinum II and adriamycin

Abstract

Access to Document

Fingerprint

Cite this